Skip to content

Jacques Suspène

École Normale Supérieure

2 papers in the library · publishing 2025

Papers

Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review

Qeios December 9, 2025 Jacques Suspène, Sarah Huet, Sabine Berteina‐raboin et al.

Alcohol use disorder involves excessive drinking, and existing medications often fail to prevent relapse. Psilocybin is being studied as a treatment for substance use disorders. This review of recent clinical trials finds that psilocybin appears to reduce craving for alcohol, but its effect on overall alcohol consumption is less clear. The authors note that future trials would benefit from larger sample sizes and standardized tests.

Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review

Preprints.org October 17, 2025 Jacques Suspène, Sarah Huet, Sabine Berteina‐raboin et al. preprint

Alcohol use disorder involves excessive drinking, and current medications often do not prevent relapse. Psilocybin is being studied for treating substance use disorders. This review of recent clinical trials finds that psilocybin appears to reduce craving, but its effect on overall alcohol consumption is less clear. Future trials would benefit from larger sample sizes and standardized tests.